Tech Company Financing Transactions
TFF Pharmaceuticals Funding Round
Private investors participated in a $8.2 million Series A funding round for TFF Pharmaceuticals. The round was announced on 5/31/2019.
Transaction Overview
Company Name
Announced On
5/31/2019
Transaction Type
Venture Equity
Amount
$8,170,000
Round
Series A
Investors
Proceeds Purpose
The proceeds from this transaction will provide additional funding for the progress of the Company's current research and development programs.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2801 Via Fortuna 425
Austin, TX 78746
USA
Austin, TX 78746
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) is a biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions. In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glenn Mattes
Chief Financial Officer
Kirk Coleman
Chief Scientific Officer
Brian Windsor
Browse more venture capital transactions:
Prev: 5/31/2019: Thrive Earlier Detection venture capital transaction
Next: 5/31/2019: OwnBackup venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs